These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29753354)

  • 1. The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries' Health Economics Practitioners: A Commentary.
    Adeagbo CU; Rattanavipapong W; Guinness L; Teerawattananon Y
    Value Health; 2018 May; 21(5):569-572. PubMed ID: 29753354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries.
    Luz A; Santatiwongchai B; Pattanaphesaj J; Teerawattananon Y
    Health Res Policy Syst; 2018 Feb; 16(1):4. PubMed ID: 29402314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.
    Wilkinson T; Sculpher MJ; Claxton K; Revill P; Briggs A; Cairns JA; Teerawattananon Y; Asfaw E; Lopert R; Culyer AJ; Walker DG
    Value Health; 2016 Dec; 19(8):921-928. PubMed ID: 27987641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries.
    Vassall A; Mangham-Jefferies L; Gomez GB; Pitt C; Foster N
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):95-115. PubMed ID: 26786617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological variation in economic evaluations conducted in low- and middle-income countries: information for reference case development.
    Santatiwongchai B; Chantarastapornchit V; Wilkinson T; Thiboonboon K; Rattanavipapong W; Walker DG; Chalkidou K; Teerawattananon Y
    PLoS One; 2015; 10(5):e0123853. PubMed ID: 25950443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to conducting economic evaluation studies of Gulf Cooperation Council (GCC) countries: a survey of researchers.
    Almazrou SH; Alaujan SS; Al-Aqeel SA
    Health Res Policy Syst; 2021 May; 19(1):71. PubMed ID: 33933093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assessment of health economic evaluation.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.
    Tordrup D; Chouaid C; Cuijpers P; Dab W; van Dongen JM; Espin J; Jönsson B; Léonard C; McDaid D; McKee M; Miguel JP; Patel A; Reginster JY; Ricciardi W; Rutten-van Molken M; Rupel VP; Sach T; Sassi F; Waugh N; Bertollini R
    Int J Technol Assess Health Care; 2017 Jan; 33(6):609-619. PubMed ID: 29081308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budget impact analysis.
    Leelahavarong P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S65-71. PubMed ID: 24964701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable?
    Yothasamut J; Tantivess S; Teerawattananon Y
    Value Health; 2009; 12 Suppl 3():S26-30. PubMed ID: 20586976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines.
    Thiboonboon K; Santatiwongchai B; Chantarastapornchit V; Rattanavipapong W; Teerawattananon Y
    Appl Health Econ Health Policy; 2016 Dec; 14(6):659-672. PubMed ID: 27475634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.